🇺🇸 FDA
Patent

US 9763984

Methods for production of platelets from pluripotent stem cells and compositions thereof

granted A61KA61K35/19A61P

Quick answer

US patent 9763984 (Methods for production of platelets from pluripotent stem cells and compositions thereof) held by Astellas Institute for Regenerative Medicine expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K35/19, A61P, A61P17/02, A61P33/06